(19)
(11) EP 0 921 133 B9

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)
Corrections, see
Claims

(48) Corrigendum issued on:
05.07.2006 Bulletin 2006/27

(45) Mention of the grant of the patent:
27.07.2005 Bulletin 2005/30

(21) Application number: 98309785.8

(22) Date of filing: 30.11.1998
(51) International Patent Classification (IPC): 
C08C 1/15(1974.07)
C08J 5/02(1974.07)

(54)

Manufacture of rubber articles

Herstellung von Gummiartikeln

Fabrication d'articles en caoutchouc


(84) Designated Contracting States:
DE FR GB

(30) Priority: 03.12.1997 US 984604

(43) Date of publication of application:
09.06.1999 Bulletin 1999/23

(60) Divisional application:
05011537.7 / 1566391

(73) Proprietor: Ansell Healthcare Products Inc.
Massillon, Ohio 44646 (US)

(72) Inventors:
  • Nile, Jeffrey G.
    Alliance, Ohio 44601 (US)
  • Gromelski, Stanley J.
    Canton, Ohio 44718 (US)
  • Gerber, Nevin D.
    New Philadelphia, Ohio 44601 (US)

(74) Representative: Meddle, Alan L. et al
FORRESTER & BOEHMERT, Pettenkoferstrasse 20-22
80336 München
80336 München (DE)


(56) References cited: : 
EP-A- 0 640 623
WO-A-96/25279
WO-A-96/23643
   
  • DATABASE WPI Section Ch, Week 8451 Derwent Publications Ltd., London, GB; Class A12, AN 84-316346 XP002094955 & JP 59 199701 A (TERUMO CORP) , 12 November 1984
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).


Description


[0001] This is a continuation-in-part of application Serial No. 08/847,323, filed April 23, 1997, which is pending.

Field of the Invention



[0002] This invention relates to powder-free rubber articles produced by latex dipping and to the methods and materials used in their manufacture. More particularly, the invention relates to the production of powder-free natural and synthetic rubber latex medical articles, such as surgical and medical gloves, condoms and catheters, by employing a powder-free coagulant during fabrication.

Background of the Invention



[0003] The manufacture of a typical latex surgical glove generally requires latex and powders, as well as water, vulcanizing agents, accelerators, activators, blockers, retarders, antioxidants, preservatives, odorants, colorants, stabilizers, and other processing aids. The powder serves two important functions in the manufacture and use of latex gloves and other products -- it facilitates the release of a glove from a glove former during manufacture and it aids the donning of the gloves during use.

[0004] Gloves are manufactured by dipping ceramic or aluminum glove formers shaped like hands into tanks of liquid latex and admixed chemicals. The formers are precoated with a coagulant to gel the latex and to facilitate the subsequent removal of the glove from the former. The precoated formers are then dipped in the tanks of chemicals necessary to make the gloves. The "wet" gloves are dried and cured in a heated oven and the latex glove cures on the mold. The outside layer of the dipped former will ultimately be the inside of the glove . While still on the formers, the latex gloves also go through one or more rinses to leach out proteins and residual chemicals before they are stripped off the mold, packaged, and sterilized. The latex contains vulcanization agents that cure the natural rubber and produce a dry rubber film. Thus, the film surface of the cured natural rubber is quite "tacky" after the glove is dried. It is therefore necessary to incorporate detackifying powders in the manufacturing process to facilitate the release of a glove from its glove former. Powders are also used to aid the donning of the gloves.

[0005] The use of powder complicates the manufacturing process and may cause respiratory problems for workers during the manufacturing process. Likewise, powder can be released into the air and inhaled when medical or health care personnel don and remove their gloves during subsequent use.

[0006] In order to reduce the likelihood of such problems, it is common practice for health care personnel to remove excess powder from the gloves after donning by wiping gloves thoroughly with a sterile sponge or sterile towel. Similarly, manufacturers attempt to minimize the amount of powder on the gloves they manufacture by including additional manufacturing steps in the glove fabrication process. For example, some manufacturers subject the fabricated gloves to air-blowing or tumbling operations to remove excess powder. Other processes include encapsulation of the powder in the gloves by dipping the formed glove in a laminate material having better donning properties than the base rubber. Yet other processes halogenate the formed gloves to remove the powder and create a smooth glove surface.

[0007] Each of the foregoing processes reduce, but do not eliminate, the problems associated with the use of powdered gloves. As a result, one process completely eliminates the use of powder. U.S. Patent No. 4,543,844 to Podell et al. discloses a powder-free article made by conventional dipping techniques. However, Podell et al. eliminates the use of powder only by using a manufacturing process substantially more complex than that of the prior art. Whereas the prior art rendered glove surfaces tack-free by washing the finished gloves in a slurry of powder, Podell et al. achieved a powder-free glove only by washing the finished glove (i.e., after removal from the former) in a surfactant or an emulsion such as an aqueous silicone solution, and drying the washed glove in a heated oven prior to a final rinse in water. Moreover, the surfactant or emulsion was effective to eliminate tack only if further steps, such as dipping the former in acid and a hydrophilic polymer, were taken prior to vulcanizing the glove and removing it from the formers. Thus, Podell et al. does not render the manufactured glove tack-free until after the glove is removed from the former on which it is made.

[0008] Because powder is used in glove manufacturing processes in order to facilitate removal of the gloves from the glove formers, such powder-free gloves are difficult to remove from their formers because they are tacky. The process required to strip such gloves is much more complicated or labor intensive and also more time consuming than it would be if the gloves on the formers were tack-free. For example, because the gloves manufactured according to Podell et al. were still tacky while on the formers, they had to be removed from their formers by manual labor. Many gloves are lost because they stick to the formers and are damaged during the removal process. It is therefore desirable to have a powder-free, tack-free glove that has good donning properties, that can be easily stripped from the glove formers following fabrication and that can be manufactured with a minimum number of processing steps.

[0009] The present invention solves the foregoing problems by providing a powder-free glove that is readily removable from the glove former following glove fabrication. The present invention also provides a powder-free coagulant and a glove fabrication process that includes that powder-free coagulant.

Summary of the Invention



[0010] Accordingly, it is an object of the present invention to provide powder-free rubber articles produced by latex dipping.

[0011] It is another object of the present invention to provide a powder-free glove that can be easily stripped from the glove formers following fabrication.

[0012] A further object of the present invention is to provide such powder-free rubber articles that are durable and provide cut and abrasion protection.

[0013] The foregoing and additional objects are realized in the present invention that provides a powder-free coagulant composition for natural and synthetic rubber latex in accordance with Claim 1.

[0014] In embodiments of the present invention, the coagulant composition may be employed in combination with a surfactant and a cationic surface active agent.

[0015] In another aspect of the present invention, there is provided a process for fabricating a powder-free, tack-free, silicone-free rubber article in accordance with Claim 10.

[0016] Articles produced in accordance with the invention include those produced by conventional latex dipping processes, such as medical and surgical gloves, condoms and catheters.

[0017] Other features, objects and advantages of the present invention will become apparent from the following detailed description and claims.

Detailed Description of the Invention



[0018] According to the present invention, various articles, and in particular gloves, may be manufactured using a variety of different techniques. According to a preferred embodiment, the gloves are produced in a mass production line where a great plurality of gloves are sequentially, rapidly and consistently produced. Such a technique conveys and manipulates multiple glove formers through a series of chemical solutions that make the glove. The formers are made of porcelain, steel or plastic. According to the standard manufacturing process, gloves may be produced directly on the formers that are conveyed from one station to the next. For example, the formers are dipped into surfactants, waxes, coagulants and natural or synthetic resins to obtain a layer of the desired characteristics. The formers can also be overdipped with a silicone emulsion. The technique allows for altering the composition, the order of application, and the method of application of ingredients that make up the layer of the glove. In addition, specific characteristics of the material, such as breathability, moisture absorbency, thickness, tensile strength, penetration resistance, stretch characteristics, flexibility and density of the finished product, may be controlled.

[0019] The glove may be built up from multiple dips into various substances. For example, the formers may be initially dipped into a composition of a powder free release agent and a coagulant. That release agent and coagulant dip supplies a release material for the subsequent removal of the finished glove from the formers. In addition, the coagulant material will destabilize subsequent liquid resin materials such as elastomers.

[0020] Alternatively the former may be first treated with a powder-free release agent and then with a coagulant. Separate applications of the powder-free release agent and coagulant may necessitate a long drying period between and after their application. Such long drying times are costly as they require modifications to a continuous dipping line. The two step method of treating the formers also requires greater temperatures than that of the one step process. As a result, more complicated parameter control is required and cost is increased. But, the mixture of coagulant and release agent for use in a single dipping step does not exhibit the degree of instability that would normally be expected due to the differing chemical characteristics of the constituents used in compounding the powder-free coagulant.

[0021] After the release agent/coagulant dip is applied, the formers are preferably conveyed to the next station in the production line where the laminate layer is applied to the formers. The laminate layer may be comprised of an elastomeric or liquid resin dip, such as natural rubber latex. Alternatively, the laminate layer may be a natural or synthetic rubber, such as synthetic latex, polyurethane, nitrile or polychloroprene. By varying the content of the latex material, the laminate layer may be varied to provide different degrees of strength, comfort and flexibility. In any event, the content of the latex applied to the former will preferably be adjusted to provide the desired gripability, protection from cuts and abrasions and liquid repellency. If desired, the gelled latex film can be overdipped with copolymers of vinyl methyl ether and maleic esters.

[0022] After the application of the laminate layer, a second coagulant dip may be applied if another laminate layer is to be applied. The second coagulant dip, which is preferably in the form of a tackifying agent, provides a medium for adherence of the laminate applied in the next step. According to an alternative technique, the formers may be immersed into an adhesive dip to provide strength and a tacky surface for the application of the next laminate layer. Such an adhesive dip may be comprised of any synthetic resin material, and preferably an elastomer. Different degrees of strength and flexibility may be obtained by varying the characteristics of the adhesive material. After application of either a second coagulant dip or an adhesive dip, the formers are conveyed to the next station where the next laminate layer is applied.

[0023] After application of one or more laminate layers, the formers are preferably passed through ovens at elevated temperatures to dry and cure and provide the final product. The gloves are then removed either manually or by an automated technique.

[0024] According to the substantially automated mass production technique described above, a great number of variations may be introduced to provide additional or different desired characteristics of the laminate in accordance with the present invention.

[0025] The preferred embodiment of the powder-free coagulant dip is a formulation including a coagulant mixed with water, a surfactant, a detackification agent, an aqueous polychloroprene and an accelerator. That embodiment permits the different functions of the discrete components to be performed in a single dipping step rather than multiple dipping steps.

[0026] According to the present invention, the coagulating solution includes an aqueous solution of a divalent cationic metal salt and a salt stable polymer. Preferably, the salt is calcium nitrate and the calcium nitrate content is between 7% and 50% by weight of the total coagulant content. More preferably, the calcium nitrate content is in a range of 30% to 45% of the total coagulant content. The coagulating agent most preferably comprises aqueous based calcium nitrate having a solids content of 60% to 70% by weight of the raw material. Other divalent cationic metals salts such as, for example, calcium chloride, zinc nitrate, zinc chloride, magnesium acetate, magnesium nitrate, aluminum nitrate and aluminum sulphate may be used individually or in combination with the calcium nitrate.

[0027] The salt stable polymer dispersion employed in the present invention is preferably a salt-stable and electrolyte-stable polychloroprene dispersion. Suitable polychloroprenes include those sold under the trade name Neoprene. The preferred embodiment in accordance with the present invention includes Neoprene 115, having a raw material solids content of about 46%. Preferably, the quantity of polychloroprene in the coagulant of the present invention is between 1% and 20% by weight of the coagulant. More preferably, the polychloroprene content is between 1% and 8% of the total coagulant content. Of course, other salt stable dispersions, such as, for example, polyurethenes available from Witco Corp., 6200 W. 51st Street, Chicago, Illinois, under the trade designations YA127-71 and YA127-79, may also be used in accordance with the invention.

[0028] A cross-linking agent to cure the salt stable polymer may also be added. Suitable cross-linking agents include dicarboxylic and tricarboxylic acids, polyamide resins and melamine formaldehyde resins. Preferably, the cross-linking agent is present in an amount between 3% and 15% by weight of the polychloroprene and more preferably, between 5% and 10% by weight of the polychloroprene.

[0029] The presence of a surfactant, or surface active agent, in the coagulant composition increases the stability of the dispersion. The surfactant also provides advantageous coagulant film forming properties because it has a greater affinity for the former than it does for the chloroprene in the dispersion. As a result, the surfactant acts as a mould release between the former and the chloroprene and thereby facilitates removal of the formed article from the former without the need for or use of powders or release agents such as silicone. In accordance with a preferred embodiment of the invention, the coagulant solution contains an amphoteric surfactant present in amounts of between 0.5% and 15% by weight of the composition. Preferably, surface active agents are present in amounts of from 1% to 10% by weight of the composition. According to the present invention, the preferred surfactant is a cationic surface active agent available from Mona Industries, 76 E. 24th Street, Patterson, New Jersey, under the trade name Phospholipid PT-L, however, other quaternary surfactants, amphoteric surfactants, triquaternary phosphate esters and betaine derivatives may be used.

[0030] Likewise, the inclusion in the coagulant solution of wax compound aids in detackification and release of the formed article from the former. Detackification agents suitable for use in accordance with the present invention include low and high density homopolymers and copolymers, microcrystalline waxes, castor waxes, long chain fatty esters, paraffin wax, bees wax and polyamide wax.


Claims

1. A powder-free coagulant composition for natural and synthetic rubber latex wherein the coagulant composition comprises an aqueous, salt stable polymer dispersion, at least one inorganic metal salt and a detackification agent selected from the group consisting of a microcrystalline wax, a castor wax, a long chain fatty ester, a paraffin wax, a bees wax and a polyamide wax.
 
2. A powder-free coagulant composition according to Claim 1 further comprising a surfactant.
 
3. A powder-free coagulant composition according to Claim 1 further comprising a cross-linking agent to cure the salt stable polymer.
 
4. A powder-free coagulant composition according to Claim 1 wherein the aqueous, salt stable polymer is selected from the group consisting essentially of polychloroprenes, polyurethanes and mixtures thereof and further wherein the aqueous, salt stable polymer is present in an amount between 1% and 20% by weight of the coagulant composition.
 
5. A powder-free coagulant composition according to Claim 1 wherein the at least one inorganic metal salt is a divalent cationic metal salt and further wherein the at least one inorganic metal salt is present in an amount between 7% and 50% by weight of the coagulant composition.
 
6. A powder-free coagulant composition according to Claim 5 wherein the at least one inorganic metal salt is selected from the group consisting essentially of calcium nitrate, calcium chloride, zinc nitrate, zinc chloride, magnesium acetate, magnesium nitrate, aluminum nitrate and aluminum sulphate and mixtures thereof.
 
7. A powder-free coagulant composition according to Claim 3 wherein the cross-linking agent is selected from the group consisting essentially of aqueous based dicarboxylic and tricarboxylic acids, polyamide resins, melamine formaldehyde resins and mixtures thereof and further wherein the cross-linking agent is present in an amount between 3% and 15% by weight of the coagulant composition.
 
8. A powder-free coagulant composition according to Claim 2 wherein the surfactant is selected from the group consisting essentially of quaternary surfactants, amphoteric surfactants, triquaternary phosphate esters, betaine derivatives and mixtures thereof and further wherein the surfactant is present in an amount between 0.5% and 15% by weight of the coagulant composition.
 
9. A process for fabricating a powder-free, tack-free rubber article which comprises:

a. dipping a shaped, pre-heated former into an aqueous, powder-free solution which solution comprises an aqueous, salt stable polychloroprene dispersion, an inorganic metal salt and a detackification agent selected from the group consisting of a microcystalline wax, a castor wax, a long chain fatty ester, a paraffin wax, a bees wax and a polyamide wax;

b. dipping the former in a solution of natural rubber latex to form a gelled latex film to create a tack-free surface for the article;

c. leaching the gelled latex film, curing the formed rubber article on the former and dry stripping the cured tack-free article from the former


 
10. A process according to Claim 9 wherein the aqueous, powder-free solution further comprises a cross-linking agent selected from the group consisting essentially of aqueous based dicarboxylic and tricarboxylic acids, polyamide resins, melamine formaldehyde resins and mixtures thereof and further wherein the cross-linking agent is present in an amount between 3% and 15% by weight of the coagulant composition.
 
11. A process according to Claim 9 wherein the aqueous, powder-free solution further comprises a surfactant selected from the group consisting essentially of quaternary surfactants, amphoteric surfactants, triquaternary phosphate esters, betaine derivatives and mixtures thereof and further wherein the surfactant is present in an amount between 0.5% and 15% by weight of the coagulant composition.
 
12. An article of manufacture made using the process of Claim 9.
 
13. An article of Claim 12 wherein the article is a glove.
 
14. The article of Claim 12 wherein the article is a condom.
 
15. An article of manufacture made using the powder-free coagulant composition of Claim 1.
 
16. A process according to Claim 9, wherein the polychloroprene content is in a range of 1% to 20% of the total coagulant content.
 
17. A process according to Claim 9, in which the inorganic salt is an aqueous solution of calcium nitrate.
 
18. A process according to Claim 17, in which the calcium nitrate content is in a range of 7% to 50% of the composition.
 
19. A process according to Claim 9, in which a cross-linking agent is added to cure the salt stable polymer dispersion.
 
20. A process according to Claim 9, wherein the aqueous powder-free solution further comprises a cationic surface active agent.
 
21. A method according to Claim 9 further comprising the step of overdipping the gelled latex film produced in step c) with copolymers of vinyl methyl ether and maleic esters.
 
22. A method according to Claim 9 further comprising the step of overdipping the former with a silicone emulsion.
 
23. A dipped rubber article made in accordance with the method of Claim 9, wherein said article comprises a medical glove.
 


Ansprüche

1. Pulverfreie Koagulatorzusammensetzung für Natur- und Synthesekautschuklatex, wobei die Koagulatorzusammensetzung eine wäßrige, salzstabile Polymerdispersion, wenigstens ein anorganisches Metallsalz und ein Entklebungsagens ausgewählt aus der Gruppe bestehend aus einem mikrokristallinen Wachs, einem Castorwachs, einem langkettigen Fettester, einem Paraffinwachs, einem Bienewachs und einem Polyamidwachs umfaßt.
 
2. Pulverfreie Koagulatorzusammensetzung nach Anspruch 1, welche weiter ein oberflächenaktives Mittel umfaßt.
 
3. Pulverfreie Koagulatorzusammensetzung nach Anspruch 1, welche weiter ein Vernetzungsmittel umfaßt, um das salzstabile Polymer auszuhärten.
 
4. Pulverfreie Koagulatorzusammensetzung nach Anspruch 1, wobei das wäßrige, salzstabile Polymer ausgewählt ist aus der Gruppe, die im wesentlichen aus Polychloroprenen, Polyurethanen und Mischungen derselben besteht, und wobei weiter das wäßrige, salzstabile Polymer in einer Menge zwischen 1 Gew.-% und 20 Gewichtsprozent der Koagulatorzusammensetzung vorliegt.
 
5. Pulverfreie Koagulatorzusammensetzung nach Anspruch 1, wobei das wenigstens eine anorganische Metallsalz ein zweiwertiges kationisches Metallsalz ist, und wobei weiter das wenigstens eine anorganische Metallsalz in einer Menge zwischen 7 Gew.-% und 50 Gewichtsprozent der Koagulatorzusammensetzung vorliegt.
 
6. Pulverfreie Koagulatorzusammensetzung nach Anspruch 5, wobei das wenigstens eine anorganische Metallsalz ausgewählt ist aus der Gruppe, die im wesentlichen aus Calciumnitrat, Calciumchlorid, Zinknitrat, Zinkchlorid, Magnesiumacetat, Magnesiumnitrat, Aluminiumnitrat und Aluminiumsulfat und Mischungen derselben besteht.
 
7. Pulverfreie Koagulatorzusammensetzung nach Anspruch 3, wobei das Vernetzungsmittel ausgewählt ist aus der Gruppe, die im wesentlichen aus auf Wasser basierten Dicarboxyl- und Tricarboxylsäuren, Polyamidharzen, Melaminformaldehydharzen und Mischungen derselben besteht, und wobei weiter das Vernetzungsmittel in einer Menge zwischen 3 Gew.-% und 15 Gew.-% der Koagulatorzusammensetzung vorliegt.
 
8. Pulverfreie Koagulatorzusammensetzung nach Anspruch 2, wobei das oberflächenaktive Mittel ausgewählt ist aus der Gruppe, die im wesentlichen aus quartären oberflächenaktiven Mitteln, amphoteren oberflächenaktiven Mitteln, triquartären Phosphatestern, Betainderivaten und Mischungen derselben besteht, und wobei weiter das oberflächenaktive Mittel in einer Menge zwischen 0,5 Gew.-% und 15 Gew.-% der Koagulatorzusammensetzung vorliegt.
 
9. Verfahren zum Herstellen eines pulverfreien, klebfreien Kautschukgegenstands, welches umfaßt:

a. Eintauchen einer geformten, vorgeheizten Tauchform in eine wäßrige, pulverfreie Lösung, wobei die Lösung eine wäßrige, salzstabile Polychloroprendispersion, ein anorganisches Metallsalz und ein Entklebungsagens ausgewählt aus der Gruppe bestehend aus einem mikrokristallinen Wachs, einem Castorwachs, einem langkettigen Fettester, einem Paraffinwachs, einem Bienewachs und einem Polyamidwachs umfaßt;

b. Eintauchen der Tauchform in eine Lösung von Naturkautschuklatex, um einen erstarrten Latexfilm zu bilden, um eine klebfreie Oberfläche für den Gegenstand zu schaffen;

c. Herauslösen des erstarrten Latexfilms, Aushärten des gebildeten Kautschukgegenstands auf der Tauchform und Trockenabziehen des ausgehärteten klebfreien Gegenstands von der Tauchform.


 
10. Verfahren nach Anspruch 9, wobei die wäßrige, klebfreie Lösung ferner ein Vernetzungsmittel umfaßt, das ausgewählt wird aus der Gruppe, die im wesentlichen aus auf Wasser basierenden Dicarboxyl- und Tricarboxylsäuren, Polyamidharzen, Melaminformaldehydharzen und Mischungen derselben besteht, und wobei weiter das Vernetzungsmittel in einer Menge zwischen 3 Gew.-% und 15 Gew.-% der Koagulatorzusammensetzung vorliegt.
 
11. Verfahren nach Anspruch 9, wobei die wäßrige, pulverfreie Lösung ferner ein oberflächenaktives Mittel umfaßt, das ausgewählt wird aus der Gruppe, die im wesentlichen aus quartären oberflächenaktiven Mitteln, amphoteren oberflächenaktiven Mitteln, triquartären Phosphatestern, Betainderivaten und Mischungen derselben besteht, und wobei das oberflächenaktive Mittel weiter in einer Menge zwischen 0,5 Gew.-% und 15 Gew.% der Koagulatorzusammensetzung vorliegt.
 
12. Herstellungsgegenstand, hergestellt unter Verwendung des Verfahrens nach Anspruch 9.
 
13. Gegenstand nach Anspruch 12, wobei der Gegenstand ein Handschuh ist.
 
14. Gegenstand nach Anspruch 12, wobei der Gegenstand ein Kondom ist.
 
15. Herstellungsgegenstand, hergestellt unter Verwendung der pulverfreien Koagulatorzusammensetzung nach Anspruch 1.
 
16. Verfahren nach Anspruch 9, wobei der Polychloroprengehalt in einem Bereich von 1 % bis 20% des gesamten Koagulatorgehalts liegt.
 
17. Verfahren nach Anspruch 9, bei dem das anorganische Salz eine wäßrige Lösung von Calciumnitrat ist.
 
18. Verfahren nach Anspruch 17, bei dem der Calciumnitratgehalt in einem Bereich von 7% bis 50% der Zusammensetzung liegt.
 
19. Verfahren nach Anspruch 9, bei welchem ein Vernetzungsmittel zugefügt wird, um die salzstabile Polymerdispersion auszahärten.
 
20. Verfahren nach Anspruch 9, wobei die wäßrige pulverfreie Lösung ferner ein kationisches oberflächenaktives Mittel umfaßt.
 
21. Verfahren nach Anspruch 9, weiter umfassend den Schritt eines Übertauchens des erstarrten Latexfilms, der in Schritt c) hergestellt worden ist, mit Copolymeren von Vinylmethylether und Maleinsäureestern.
 
22. Verfahren nach Anspruch 9, weiter umfassend den Schritt eines Übertauchens der Tauchform mit einer Silikonemulsion.
 
23. Eingetauchter Kautschukgegenstand, hergestellt gemäß dem Verfahren von Anspruch 9, wobei der Gegenstand einen Medizinhandschuh umfaßt.
 


Revendications

1. Composition de coagulant sans poudre pour latex en caoutchouc naturel et synthétique, dans laquelle la composition de coagulant comprend une dispersion aqueuse de polymère stable en sel, au moins un sel métallique inorganique et un agent de décollement choisi dans le groupe constitué par une cire microcristalline, une cire de ricin, un ester gras à longue chaîne, une cire de paraffine, une cire d'abeille et une cire de polyamide.
 
2. Composition de coagulant sans poudre selon la Revendication 1, comprenant en outre un agent tensioactif.
 
3. Composition de coagulant sans poudre selon la Revendication 1, comprenant en outre un agent de réticulation destiné à durcir le polymère stable en sel.
 
4. Composition de coagulant sans poudre selon la Revendication 1, dans laquelle le polymère aqueux stable en sel est choisi dans le groupe constitué essentiellement par les polychloroprènes, les polyuréthanes et les mélanges de ceux-ci et dans laquelle en outre le polymère aqueux stable en sel est présent en une quantité comprise entre 1% et 20% en poids de la composition de coagulant.
 
5. Composition de coagulant sans poudre selon la Revendication 1, dans laquelle le au moins un sel métallique inorganique est un sel métallique cationique divalent et dans laquelle en outre le au moins un sel métallique inorganique est présent en une quantité comprise entre 7% et 50% en poids de la composition de coagulant.
 
6. Composition de coagulant sans poudre selon la Revendication- 5, dans laquelle le au moins un sel métallique inorganique est choisi dans le groupe constitué essentiellement par le nitrate de calcium, le chlorure de calcium, le nitrate de zinc, le chlorure de zinc, l'acétate de magnésium, le nitrate de magnésium, le nitrate d'aluminium, le sulfate d'aluminium et les mélanges de ceux-ci.
 
7. Composition de coagulant sans poudre selon la Revendication 3, dans laquelle l'agent de réticulation est choisi dans le groupe constitué essentiellement par les acides dicarboxyliques et tricarboxyliques à base aqueuse, les résines de polyamide, les résines de mélamine formaldéhyde et les mélanges de ceux-ci et dans laquelle en outre l'agent de réticulation est présent en une quantité comprise entre 3% et 15% en poids de la composition de coagulant.
 
8. Composition de coagulant sans poudre selon la Revendication 2, dans laquelle l'agent tensioactif est choisi dans le groupe constitué essentiellement par les agents tensioactifs quaternaires, les agents tensioactifs amphotères, les esters phosphates triquaternaires, les dérivés de bétaïne et les mélanges de ceux-ci et dans laquelle en outre l'agent tensioactif est présent en une quantité comprise entre 0,5% et 15% en poids de la composition de coagulant.
 
9. Procédé de fabrication d'un article en caoutchouc sans poudre sans collant, qui comprend :

a. l'immersion d'un gabarit conformateur préchauffé façonné dans une solution aqueuse sans poudre laquelle solution comprend une dispersion aqueuse de polychloroprène stable en sel, un sel métallique inorganique et un agent de décollement choisi dans le groupe constitué par une cire microcristalline, une cire de ricin, un ester gras à longue chaîne, une cire de paraffine, une cire d'abeille et une cire de polyamide ;

b. l'immersion du gabarit conformateur dans une solution de latex en caoutchouc naturel pour former un film en latex gélifié pour créer une surface sans collant pour l'article ;

c. le lessivage du film en latex gélifié, le durcissement de l'article en caoutchouc formé sur le gabarit conformateur et le retrait à sec de l'article sans collant durci du gabarit conformateur.


 
10. Procédé selon la Revendication 9, selon lequel la solution aqueuse sans poudre comprend en outre un agent de réticulation choisi dans le groupe constitué essentiellement par les acides dicarboxyliques et tricarboxyliques à base aqueuse, les résines de polyamide, les résines de mélamine formaldéhyde et les mélanges de ceux-ci et selon lequel en outre l'agent de réticulation est présent en une quantité comprise entre 3% et 15% en poids de la composition de coagulant.
 
11. Procédé selon la Revendication 9, selon lequel la solution aqueuse sans poudre comprend en outre un agent tensioactif choisi dans le groupe constitué essentiellement par les agents tensioactifs quaternaires, les agents tensioactifs amphotères, les esters phosphates triquaternaires, les dérivés de bétaïne et les mélanges de ceux-ci et selon lequel en outre l'agent tensioactif est présent en une quantité comprise entre 0,5% et 15% en poids de la composition de coagulant.
 
12. Article de manufacture produit en utilisant le procédé de la Revendication 9.
 
13. Article selon la Revendication 12, selon lequel l'article est un gant.
 
14. Article selon la Revendication 12, selon lequel l'article est un préservatif.
 
15. Article de manufacture fabriqué en utilisant la composition de coagulant sans poudre de la Revendication 1.
 
16. Procédé selon la Revendication 9, selon lequel la teneur en polychloroprène est dans une gamme de 1% à 20% de la teneur totale en coagulant.
 
17. Procédé selon la Revendication 9, selon lequel le sel inorganique est une solution aqueuse de nitrate de calcium.
 
18. Procédé selon la Revendication 17, selon lequel la teneur en nitrate de calcium est dans une gamme de 7% à 50% de la composition.
 
19. Procédé selon la Revendication 9, selon lequel un agent de réticulation est ajouté pour durcir la dispersion de polymère stable en sel.
 
20. Procédé selon la Revendication 9, selon lequel la solution aqueuse sans poudre comprend en outre un agent tensioactif cationique.
 
21. Procédé selon la Revendication 9, comprenant en outre l'étape de surimmersion du film en latex gélifié produit à l'étape c) avec des copolymères de vinyl méthyl éther et d'esters maléiques.
 
22. Procédé selon la Revendication 9, comprenant en outre l'étape de surimmersion du gabarit conformateur avec une émulsion de silicone.
 
23. Article en caoutchouc immergé produit selon le procédé de la Revendication 9, selon lequel ledit article comprend un gant médical.